Figure 1
Meta-analysis of studies of chondroitin sulphate and glucosamine and the risk of CRC. Estimated heterogeneity variance = 0.01, P = 0.99.
Figure 1 | Scientific Reports
Meta-analysis of studies of chondroitin sulphate and glucosamine and the risk of CRC. Estimated heterogeneity variance = 0.01, P = 0.99.
